Search for: "PHARMA INVESTMENT LTD." Results 21 - 40 of 63
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2017, 11:35 am by Nate Nead
China’s Sanpower Group Co., Ltd. acquired Dendreon Pharmaceuticals Inc for $0.8 billion, and Sumitomo Dainippon Pharma Co., Ltd. acquired Tolero Pharmaceuticals Inc. for $0.8 billion to assist Sumitomo to refresh its pipeline.[28] In Q4 2017, a few M&A transactions have occurred in the pharma deal market. [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Daiichi Sankyo Company, Ltd. v. [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
Flexible Obviousness Test Does Not Apply to Secondary Indicia of Nonobviousness: In Cubist Pharma v. [read post]
1 Feb 2016, 10:43 am by Lawrence B. Ebert
Hoffman-La Roche Ltd., 580 F.3d 1340,1369 (Fed. [read post]
16 Feb 2015, 1:44 am
  * "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]
15 Dec 2014, 7:25 am
.* Hurray for judicial sense on product by process claims- Birss triumphs in Hospira v GenentechThis note from Darren is about Hospira v Genentech [on which see the IPKat note here], a pharma-patent case that Mr Justice Birss has decided in light of product-by-process claims. [read post]
23 Dec 2012, 11:00 am by Shan Kohli
 Most feel that the recent changes to the calculation of prices will definitely bring down prices of drugs but will severely hit the larger players (who may have to take a hit of about 15%-20% in revenues) in the market which could in turn effect investment in the sector. [read post]
6 Apr 2012, 6:42 am by Lindsay Griffiths
  INDIA’S BATTLE UNDER BILATERAL INVESTMENT TREATIES from LexCounsel: LexCounsel examines the recent uptick in arbitrations regarding the Government of India's execution of Bilateral Investment Treaties, and the impact this may have on inbound investment. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
11 Jan 2011, 11:07 pm by Kelly
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques… [read post]
13 Dec 2010, 11:13 am by sally
Court of Appeal (Civil Division) Carroll v Kynaston [2010] EWCA Civ 1404 (13 December 2010) High Court (Queen’s Bench Division) Smith v ADVFN Plc & Ors [2010] EWHC 3255 (QB) (13 December 2010) High Court (Administrative Court) Public Interest Lawyers v Legal Services Commission [2010] EWHC 3277 (Admin) (13 December 2010) High Court (Patents Court) Pfizer Health AB & Anor v Schwarz Pharma AG & Ors [2010] EWHC 3236 (Pat) (08 December 2010) High Court (Commercial Court)… [read post]
16 Sep 2010, 1:22 pm by Bexis
GSK is pharma company with a large local presence (for more about that, see this post). [read post]
1 Aug 2009, 1:14 am
More importantly, the iZumi story illustrates why the CIRM approach to intellectual property (and on return on investment to California taxpayers) is fundamentally flawed. [read post]
6 Jul 2009, 8:48 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: EPO sets deadline for presidential applications; Jesper Kongstad, Benoît Battistelli enter the fray in battle to be next EPO President (Managing Intellectual Property) (IAM) (IAM) ECJ: Dutch brewer allowed to use Italian BAVARIA trade marks despite ‘Bayerisches Bier’ (Bavarian Beer) PGI: Bavaria NV and Bavaria… [read post]